Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Matthew B. Burruss"'
1
Prospective Assessment of Postoperative Nausea Early After Bariatric Surgery
Autor: Konstantinos Spaniolas, Lilly Bayouth, Matthew B. Burruss, Adam C. Celio
Publikováno v: Obesity Surgery. 29:858-861
The most common reason for readmission after bariatric surgery is postoperative nausea and vomiting (PONV). The aim of this study was to compare the incidence and severity of PONV between patients undergoing laparoscopic sleeve gastrectomy (SG) and g
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a133332604a234ac4ecc7c7c2aab232b
https://doi.org/10.1007/s11695-018-3605-1
Zobrazit plný text záznamu
2
Postoperative Follow-up After Bariatric Surgery: Effect on Weight Loss
Autor: Adam C. Celio, Konstantinos Spaniolas, Matthew B. Burruss, Walter J. Pories, Kevin R. Kasten
Publikováno v: Obesity Surgery. 26:900-903
While adherence to long-term follow-up after bariatric surgery is a mandate for center of excellence certification, the effect of attrition on weight loss is not well understood. The aim of this study was to assess the effect of postoperative follow-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2bbdccd3bdcf30195c762ba92477899
https://doi.org/10.1007/s11695-016-2059-6
Zobrazit plný text záznamu
3
Surgeon case volume and readmissions after laparoscopic Roux-en-Y gastric bypass: more is less
Autor: Adam C. Celio, Kevin R. Kasten, Walter J. Pories, Matthew B. Burruss, Konstantinos Spaniolas
Publikováno v: Surgical endoscopy. 31(3)
Laparoscopic Roux-en-Y gastric bypass (LRYGB) is a commonly performed bariatric procedure. Readmissions are used as a quality indicator with a nationwide emphasis on reduction. In LRYGB surgery, surgeon volume studies have focused on correlation with
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c1dc4a6767afd2dbbd18e26104b8ecd
https://pubmed.ncbi.nlm.nih.gov/27444838
Zobrazit plný text záznamu
4
PS10. Perioperative Administration of Alvimopan, a Novel Peripherally Acting Mu-opioid Receptor Antagonist, Is Associated with Improved Resource Utilization in Patients Undergoing Open Aortic Surgery
Autor: Matthew B. Burruss, Frank M. Parker, Timothy W. Capps, Charles S. Powell, Bryan A. Ehlert, Michael C. Stoner, William M. Bogey
Publikováno v: Journal of Vascular Surgery. 55(6)
eurysm sac embolization during EVAR (edEVAR) with coils and glue, in the prevention of Endoleak type II (ET2). Methods: Two groups were compared: 85 patients underwent standard EVAR during 2007-2008 (Group A) and 81 patients underwent edEVAR during 2
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7263ca9407ae277d0935f061c5945f1a
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje